The Sackler family and Purdue Pharma have agreed to pay a $7.4 billion settlement to end federal court claims filed by ...

The individuals behind Purdue Pharma’s involvement in the U.S. opioid crisis reached a $7-billion settlement in January 2025.

Purdue Pharma and its owners, the Sackler family, have reached a $7.4bn settlement with US states to resolve a long-running ...

Colorado is set to receive around $81 million from a $7.4 billion preliminary settlement with Purdue Pharma, the company’s ...

The settlement, in principle, would not shield Purdue Pharma or the Sackler family from additional liability over their role in the opioid crisis.

The Sackler family and Purdue Pharma, the maker of the addictive painkiller oxycontin, have reached a $7.4 billion settlement ...

The Sackler family and Purdue Pharma, maker of OxyContin, have increased their settlement offer to $7.4 billion amid ongoing ...

The Sackler family and Purdue Pharma have agreed to a $7.4 billion settlement to resolve federal claims brought by attorneys ...

Purdue Pharma and its owners, the Sackler family, have reached a $7.4bn settlement with US states to resolve a long-running legal saga involving the pain medication Oxycontin and its role in ...

Purdue Pharma, the manufacturers of OxyContin, and members of the family that own the company, will pay billions to victims ...

The latest settlement is meant to address a drug addiction crisis that has led to over 700,000 opioid overdose deaths in the US over the past two decades.